| |
E-DII score negative (n = 113)
|
E-DII score positive (n = 64)
|
p value
|
Effect size
|
|---|
|
Women
|
103 (91)
|
48 (75)
|
0.007
|
0.22
|
|
Age (years)
|
62.0 (17.0)
|
59.5 (25.0)
|
0.13
|
0.09
|
|
Height (cm)
|
154.5 (9.9)
|
156.7 (13.5)
|
0.19
|
0.09
|
|
Weight (kg)
|
52.3 (13.4)
|
55.5 (15.1)
|
0.017
|
0.12
|
|
BMI (kg/m2)
|
22.0 (5.3)
|
22.9 (5.1)
|
0.06
|
0.10
|
|
Smoking
|
27 (24)
|
24 (38)
|
0.06
|
0.14
|
|
Drinking habits
|
42 (37)
|
36 (56)
|
0.018
|
0.19
|
|
RF (IU/ml)
|
46 (108)
|
40 (89)
|
0.49
|
0.06
|
|
RF positive
|
86 (76)
|
48 (75)
|
0.86
|
0.01
|
|
Anti-CCP (U/ml)
|
61.1 (86.2)
|
88.5 (89.9)
|
0.45
|
0.07
|
|
Anti-CCP positive
|
94 (83)
|
58 (91)
|
0.26
|
0.10
|
|
RA duration (years)
|
12.2 (17.4)
|
8.1 (12.5)
|
0.037
|
0.11
|
|
csDMARD user
|
102 (90)
|
60 (94)
|
0.58
|
0.06
|
|
bDMARD user
|
65 (58)
|
39 (61)
|
0.75
|
0.03
|
|
GC user
|
27 (24)
|
20 (31)
|
0.29
|
0.08
|
|
ESR (mm/h)
|
23 (27)
|
16 (25)
|
0.005
|
0.13
|
|
MMP-3 (ng/ml)
|
60.8 (63.0)
|
72.3 (93.8)
|
0.33
|
0.07
|
|
hs-CRP (mg/l)
|
0.13 (0.36)
|
0.09 (0.43)
|
0.72
|
0.05
|
|
mHAQ-DI
|
0.25 (0.81)
|
0.25 (0.97)
|
0.43
|
0.07
|
|
TJC
|
2 (6)
|
1 (3)
|
0.06
|
0.10
|
|
SJC
|
0 (2)
|
0 (2)
|
0.44
|
0.07
|
|
Patient VAS
|
30 (40)
|
24 (40)
|
0.60
|
0.05
|
|
DAS28-ESR
|
3.6 (2.2)
|
3.2 (1.7)
|
0.007
|
0.12
|
- In Age, Height, Weight, BMI, RF, Anti-CCP, RA duration, ESR, MMP-3, hs-CRP, mHAQ-DI, TJC, SJC, Patient VAS, DAS28-ESR, data were showed as median (interquartile range) and other categorical data were shown as patient number (%). There was no patient showed E-DII score zero. bDMARDs biological disease-modifying antirheumatic drugs, BMI body mass index, CCP anti-cyclic citrullinated peptide antibody, csDMARDs conventional synthetic disease-modifying antirheumatic drugs, DAS28-ESR disease activity scores in 28 joints using erythrocyte sedimentation rates, E-DII energy-adjusted dietary inflammatory index, GC glucocorticoid, hs-CRP high-sensitivity C-reactive protein, mHAQ-DI modified health assessment questionnaire disability index, MMP matrix metalloproteinase, RA rheumatoid arthritis, RF rheumatoid factor, SJC swollen joint count, TJC tender joint count, VAS visual analog scale
